Watch HCA. Know when insiders buy.
One email the day a filing lands. Free.
Work order
47
WATCH · shorts 47
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
2 / 0
buys / sells · latest disclosed Jul 26
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $89.8BP/E 13.9DIV YIELD 0.73%FCF YIELD 8.82%REV TTM $76.4B +6.7%NET INCOME $6.8B +17.6%NET DEBT $43.4B52W 361.32 – 545.13SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $19.1B | +4.3% | — | — | $1.6B | +0.6% | 7.15 | $2B | $1.1B | $895M | Apr 29 |
| Q4 2025 · Dec 31 | $19.5B | +6.7% | — | — | $1.9B | +30.6% | 8.10 | $2.4B | $1.5B | $870M | Apr 29 |
| Q3 2025 · Sep 30 | $19.2B | +9.6% | — | — | $1.6B | +29.4% | 6.96 | $4.4B | $1.3B | $3.1B | Apr 29 |
| Q2 2025 · Jun 30 | $18.6B | +6.4% | — | — | $1.7B | +13.1% | 6.83 | $4.2B | $1.2B | $3B | Apr 29 |
| Q1 2025 · Mar 31 | $18.3B | +5.7% | — | — | $1.6B | +1.2% | 6.45 | $1.7B | $991M | $660M | Apr 29 |
| Q4 2024 · Dec 31 | $18.3B | +5.7% | — | — | $1.4B | −10.5% | 5.63 | $2.6B | $1.3B | $1.3B | Feb 10 |
| Q3 2024 · Sep 30 | $17.5B | +7.9% | — | — | $1.3B | +17.7% | 4.88 | $3.5B | $1.2B | $2.3B | Oct 30 |
| Q2 2024 · Jun 30 | $17.5B | +10.3% | — | — | $1.5B | +22.5% | 5.53 | $2B | $1.3B | $690M | Oct 30 |
| Q1 2024 · Mar 31 | $17.3B | — | — | — | $1.6B | — | 5.93 | $2.5B | $1.1B | $1.4B | Oct 30 |
| Q4 2023 · Dec 31 | $17.3B | — | — | — | $1.6B | — | 5.90 | $2.7B | $1.2B | $1.5B | Feb 10 |
| Q3 2023 · Sep 30 | $16.2B | — | — | — | $1.1B | — | 3.91 | $2.5B | $1.1B | $1.3B | Oct 31 |
| Q2 2023 · Jun 30 | $15.9B | — | — | — | $1.2B | — | 4.29 | $2.5B | $1.2B | $1.2B | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $75.6B | — | — | $6.8B | 9.0% | 28.33 | $12.6B | $4.9B | $7.7B | $10.1B | $679M |
| FY2024 · to Dec 31 | $70.6B | — | — | $5.8B | 8.2% | 22.00 | $10.5B | $4.9B | $5.6B | $6B | $690M |
| FY2023 · to Dec 31 | $65B | — | — | $5.2B | 8.1% | 18.97 | $9.4B | $4.7B | $4.7B | $3.8B | $661M |
| FY2022 · to Dec 31 | $60.2B | — | — | $5.6B | 9.4% | 19.15 | $8.5B | $4.4B | $4.1B | $7B | $653M |
| FY2021 · to Dec 31 | $58.8B | — | — | $7B | 11.8% | 21.16 | $9B | $3.6B | $5.4B | $8.2B | $624M |
| FY2020 · to Dec 31 | $51.5B | — | — | $3.8B | 7.3% | 10.93 | $9.2B | $2.8B | $6.4B | $441M | $153M |
Every number comes from HCA Healthcare, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.